Dronabinol for the treatment of agitation and aggressive behavior in acutely hospitalized severely demented patients with noncognitive behavioral symptoms

American Journal of Geriatric Psychiatry

Volumn 22, Issue 4, 2014, Pages 415-419

  Woodward, Matthew R ^a   Harper, David G ^a   Stolyar, Arkadiy ^a   Forester, Brent P ^a   Ellison, James M ^a  

^a MCLEAN HOSPITAL   (United States)

Author keywords

Behavioral disturbances; Dementia; Dronabinol

Indexed keywords

DRONABINOL;

AGGRESSION; AGGRESSIVENESS; AGITATION; ANESTHESIA COMPLICATION; APPETITE; AROUSAL; ARTICLE; BEHAVIOR DISORDER; BODY WEIGHT; CLINICAL ARTICLE; CLINICAL GLOBAL IMPRESSION SCALE; CONFUSION; DELIRIUM; DEMENTIA; DISEASE SEVERITY; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG SAFETY; DSM-IV-TR; FEMALE; FOLLOW UP; FOOD INTAKE; FRONTOTEMPORAL DEMENTIA; GLOBAL ASSESSMENT OF FUNCTIONING; HUMAN; MALE; MEAL; MEDICAL RECORD; MINI MENTAL STATE EXAMINATION; MULTIINFARCT DEMENTIA; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PITTSBURGH AGITATION SCALE; PSYCHIATRIST; RETROSPECTIVE STUDY; SEDATION; SLEEP TIME; TREATMENT DURATION; TREATMENT RESPONSE; URINARY TRACT INFECTION;

BEHAVIORAL DISTURBANCES; DEMENTIA; DRONABINOL;

AGGRESSION; ANOREXIA; ANTIDEPRESSIVE AGENTS; ANTIPSYCHOTIC AGENTS; CANNABINOID RECEPTOR AGONISTS; CHOLINESTERASE INHIBITORS; COHORT STUDIES; DEMENTIA; DRONABINOL; DRUG THERAPY, COMBINATION; FEMALE; HOSPITALIZATION; HUMANS; MALE; MENTAL DISORDERS; PSYCHOMOTOR AGITATION; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 84898847600     PISSN: 10647481     EISSN: 15457214     Source Type: Journal    
DOI: 10.1016/j.jagp.2012.11.022     Document Type: Article

References (10)

1. Ikeda M, Fukuhara R, Shigenobu K, et al: Dementia associated mental and behavioural disturbances in elderly people in the community: findings from the first Nakayama study. J Neurol Neurosurg Psychiatry 2004; 75:146-148
2. Cohen-Mansfield J, Billig N: Agitated behaviors in the elderly. I. A conceptual review. J Am Geriatr Soc 1986; 34:711-721
3. Bartels SJ, Horn SD, Smout RJ, et al: Agitation and depression in frail nursing home elderly patients with dementia: treatments and characteristics of service use. AmJ Geriatr Psychiatry 2003; 11:231-238
4. Allegri RF, Sarasola D, Serrano CM, et al: Neuropsychiatric symptoms as a predictor of caregiver burden in Alzheimer's disease. Neuropsychiatr Dis Treat 2006; 2:105-110
5. Ballard C, Waite J: The effectiveness of atypical antipsychotics for the treatment of aggression and psychosis in Alzheimer's disease. Cochrane Database of Systematic Reviews (Online) 2006;(1): CD003476
6. Volicer L, Stelly M, Morris J, et al: Effects of dronabinol on anorexia and disturbed behavior in patients with Alzheimer's disease. Int J Geriatr Psychiatry 1997; 12:913-919
7. Walther S, Mahlberg R, Eichmann U, et al: Delta-9-tetrahydrocannabinol for nighttime agitation in severe dementia. Psychopharmacology 2006; 185:524-528
8. Andre C, Jaber-Fihlo JA, Bento RM, et al: Delirium following ingestion of marijuana present in chocolate cookies. CNS Spectr 2006; 11:262-264
9. Ramírez BG, Blazquez C, Gomez del Pulgar DP, et al: Prevention of Alzheimer's disease pathology by cannabinoids: neuroprotection mediated by blockade of microglial activation. J Neurosci 2005; 25:1904-1913
10. Eubanks LM, Rogers CJ, Beuscher AE, et al: A molecular link between the active component of marijuana and Alzheimer's disease pathology. Mol Pharmacol 2006; 3:773-777